These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 33147616)

  • 1. Computational drug repositioning based on multi-similarities bilinear matrix factorization.
    Yang M; Wu G; Zhao Q; Li Y; Wang J
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33147616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repositioning based on multi-view learning with matrix completion.
    Yan Y; Yang M; Zhao H; Duan G; Peng X; Wang J
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35289352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm.
    Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y
    Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
    Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
    Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repositioning based on bounded nuclear norm regularization.
    Yang M; Luo H; Li Y; Wang J
    Bioinformatics; 2019 Jul; 35(14):i455-i463. PubMed ID: 31510658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repositioning through integration of prior knowledge and projections of drugs and diseases.
    Xuan P; Cao Y; Zhang T; Wang X; Pan S; Shen T
    Bioinformatics; 2019 Oct; 35(20):4108-4119. PubMed ID: 30865257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous graph inference with matrix completion for computational drug repositioning.
    Yang M; Huang L; Xu Y; Lu C; Wang J
    Bioinformatics; 2021 Apr; 36(22-23):5456-5464. PubMed ID: 33331887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network-based drug repurposing method via non-negative matrix factorization.
    Sadeghi S; Lu J; Ngom A
    Bioinformatics; 2022 Feb; 38(5):1369-1377. PubMed ID: 34875000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDAPRED: a computational method for predicting drug repositioning using regularized logistic matrix factorization.
    Wang X; Yan R
    J Mol Model; 2020 Feb; 26(3):60. PubMed ID: 32062701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional Neural Matrix Factorization model for computational drug repositioning.
    Yang X; Zamit L; Liu Y; He J
    BMC Bioinformatics; 2019 Aug; 20(1):423. PubMed ID: 31412762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of various protein similarities using random forest technique to infer augmented drug-protein matrix for enhancing drug-disease association prediction.
    Kitsiranuwat S; Suratanee A; Plaimas K
    Sci Prog; 2022; 105(3):368504221109215. PubMed ID: 35801312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlap matrix completion for predicting drug-associated indications.
    Yang M; Luo H; Li Y; Wu FX; Wang J
    PLoS Comput Biol; 2019 Dec; 15(12):e1007541. PubMed ID: 31869322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix factorization-based data fusion for the prediction of lncRNA-disease associations.
    Fu G; Wang J; Domeniconi C; Yu G
    Bioinformatics; 2018 May; 34(9):1529-1537. PubMed ID: 29228285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning.
    Kim Y; Jung YS; Park JH; Kim SJ; Cho YR
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DRIMC: an improved drug repositioning approach using Bayesian inductive matrix completion.
    Zhang W; Xu H; Li X; Gao Q; Wang L
    Bioinformatics; 2020 May; 36(9):2839-2847. PubMed ID: 31999326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Computational Drug-Repositioning by Self-Paced Non-Negative Matrix Tri-Factorization.
    Dang Q; Liang Y; Ouyang D; Miao R; Ling C; Liu X; Xie S
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(3):1953-1962. PubMed ID: 36445996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting drug-disease associations by using similarity constrained matrix factorization.
    Zhang W; Yue X; Lin W; Wu W; Liu R; Huang F; Liu F
    BMC Bioinformatics; 2018 Jun; 19(1):233. PubMed ID: 29914348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces.
    Chen H; Zhang Z; Zhang J
    BMC Bioinformatics; 2021 Feb; 22(1):52. PubMed ID: 33557749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A drug repositioning algorithm based on a deep autoencoder and adaptive fusion.
    Chen P; Bao T; Yu X; Liu Z
    BMC Bioinformatics; 2021 Oct; 22(1):532. PubMed ID: 34717542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.